A phase I/II clinical trial of ECT204 T cells in adult subjects with advanced Hepatocellular Carcinoma (HCC). The study is currently in phase II and will be conducted at multiple sites.
Study Status: This study is currently recruiting participants. For additional information, please visit clinicaltrials.gov.
To learn more about participating in this clinical trial, please contact us .
A phase 1/2 clinical trial of ET140203 T cells in pediatric subjects with relapsed/refractory Hepatoblastoma (HB), Hepatocellular Neoplasm-Not Otherwise Specified (HCN-NOS), or Hepatocellular Carcinoma (HCC). The study includes a dose escalation and expansion phase and will be conducted at multiple sites.
Study Status: This study is currently recruiting participants. For additional information, please visit clinicaltrials.gov.
To learn more about participating in this clinical trial, please contact us .
Financial assistance is available to support those interested in participating in the clinical trial who do not live near a participating site, on a case-by-case basis. Eureka makes no guarantee with respect to reimbursement or copay assistance for any item or service.
Your T cells, fighting your specific type of cancer. See the schematic below to learn more about the patient and T cell journey.
To learn more about participating in our clinical trials, click the link below.
EUREKA THERAPEUTICS, ARTEMIS, and E-ALPHA are registered trademarks owned by Eureka Therapeutics, Inc.